What is RAPT's dilution risk score?

RAPT has a latest available DilutionScore record of 52/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for RAPT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for RAPT?

DilutionWatch tracks 25 SEC filing types for RAPT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RAPT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RAPT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RAPT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RAPT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RAPT Dilution Risk Score: 52/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

40

📊 Float Risk

30

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for RAPT.

🔔 Track RAPT — Get forecast alerts →

Market Data

Market Cap$1.68B

Shares Outstanding27.71M

Float16.85M

Cash$157.34M

Debt$2.60M

Short InterestN/A

Institutional Holdings

QoQ: ↓ 80.1% shares (2026Q1 vs prior)

1 institutional holders · 589.0K shares

#1 BARCLAYS PLC 589.0K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-12-31

4 INSIDER TRANSACTION 2026-03-05

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual RAPT Dilution Snapshot

RAPT Therapeutics Inc (RAPT) has a DilutionScore of 52/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for RAPT: 4 on 2026-03-05; 4 on 2026-03-05; 4 on 2026-03-05.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.